Corresponding Author: Alex H. Krist, MD, MPH, Virginia Commonwealth University, One Capitol Square, 830 E Main St, Sixth Floor, Richmond, VA 23219 (firstname.lastname@example.org).
Accepted for Publication: March 17, 2021.
The US Preventive Services Task Force (USPSTF) members: Alex H. Krist, MD, MPH; Karina W. Davidson, PhD, MASc; Carol M. Mangione, MD, MSPH; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; James Stevermer, MD, MSPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of California, Los Angeles (Mangione); Albert Einstein College of Medicine, New York, New York (Cabana); Oregon Health & Science University, Portland (Caughey); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); University of Missouri, Columbia (Stevermer); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Krist had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Brandy Peaker, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
AL ; US Preventive Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med
. 2015;163(10):778-786. doi:10.7326/M15-2223PubMedGoogle ScholarCrossref
S , Clarke
R , Qizilbash
N , Peto
R , Collins
R ; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet
. 2002;360(9349):1903-1913. doi:10.1016/S0140-6736(02)11911-8PubMedGoogle ScholarCrossref
National High Blood Pressure Education Program. The Seventh Report on the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health; 2004.
PK , Carey
RM , Aronow
et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension
. 2018;71(6):e13-e115.PubMedGoogle Scholar
JM , Evans
CV , Webber
EM , Coppola
EL , Perdue
LA , Weyrich
MS . Screening for Hypertension in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 197. Agency for Healthcare Research and Quality; 2021. AHRQ publication 20-05265-EF-1.
JM , Evans
CV , Webber
EM , Coppola
EL , Perdue
LA , Weyrich
MS . Screening for hypertension in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA
. Published April 27, 2021. doi:10.1001/jama.2020.21669Google Scholar
EJ , Blaha
MJ , Chiuve
et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation
. 2017;135(10):e146-e603. doi:10.1161/CIR.0000000000000485PubMedGoogle ScholarCrossref
PA , Oparil
S , Carter
et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA
. 2014;311(5):507-520. doi:10.1001/jama.2013.284427PubMedGoogle ScholarCrossref
SJ , Krist
AH , Owens
et al; US Preventive Services Task Force. Risk assessment for cardiovascular disease with nontraditional risk factors: US Preventive Services Task Force recommendation statement. JAMA
. 2018;320(3):272-280. doi:10.1001/jama.2018.8359PubMedGoogle ScholarCrossref
SJ , Krist
AH , Owens
et al; US Preventive Services Task Force. Screening for atrial fibrillation with electrocardiography: US Preventive Services Task Force recommendation statement. JAMA
. 2018;320(5):478-484. doi:10.1001/jama.2018.10321PubMedGoogle ScholarCrossref
ML ; US Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med
. 2014;161(8):587-593. doi:10.7326/M14-1796PubMedGoogle ScholarCrossref
DC , Bibbins-Domingo
K , Curry
et al; US Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement. JAMA
. 2017;318(2):167-174. doi:10.1001/jama.2017.7171PubMedGoogle ScholarCrossref
K , Grossman
DC , Curry
et al; US Preventive Services Task Force. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA
. 2016;316(19):1997-2007. doi:10.1001/jama.2016.15450PubMedGoogle ScholarCrossref
K ; US Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med
. 2016;164(12):836-845. doi:10.7326/M16-0577PubMedGoogle ScholarCrossref
J , Chambers
LW , Dolovich
et al. Improving cardiovascular health at population level: 39-community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ
. 2011;342:d442. doi:10.1136/bmj.d442PubMedGoogle ScholarCrossref
SD , Cuccurullo
F . Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens
. 2011;24(1):52-58. doi:10.1038/ajh.2010.203PubMedGoogle ScholarCrossref
K , Thijs
L , Li
et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension
. 2014;64(5):935-942. doi:10.1161/HYPERTENSIONAHA.114.03614PubMedGoogle ScholarCrossref
JB , Lotito
MJ , Trivedi
UK , Denker
MG , Cohen
DL , Townsend
RR . Cardiovascular events and mortality in white coat hypertension: a systematic review and meta-analysis. Ann Intern Med
. 2019;170(12):853-862. doi:10.7326/M19-0223PubMedGoogle ScholarCrossref
YC , Shimbo
D , Muntner
P , Moran
AE , Krakoff
LR , Schwartz
JE . Prevalence of masked hypertension among US adults with nonelevated clinic blood pressure. Am J Epidemiol
. 2017;185(3):194-202. doi:10.1093/aje/kww237PubMedGoogle Scholar
D , Artinian
NT , Basile
et al; American Heart Association and the American Medical Association. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation
. 2020;142(4):e42-e63. doi:10.1161/CIR.0000000000000803PubMedGoogle ScholarCrossref